GO
Loading...

Enter multiple symbols separated by commas

Medicine

More

  • A study conducted at the University of Sydney found that nicotinamide, a form of vitamin B3, reduced by 23 percent the incidence of new, non-melanoma skin cancers in people who had at least two of the cancers in the previous five years. "It's a cheap vitamin... one could be generous about starting it early if that's a preference," said Dr Peter Paul Yu, ASCO president and...

  • Investors were waiting for news that could move share prices from many bigger companies including Bristol-Meyers Squibb Co, Amgen Inc and Celgene Corp. Hot topics at the American Society of Clinical Oncology conference in Chicago will include immuno oncology and CAR-T cell therapies. Shares in Juno Therapeutics Inc, Kite Pharma Inc, BlueBird Bio Inc and...

  • May 12- A trial assessing the cardiovascular safety of obesity drug Contrave, made by Orexigen Therapeutics Inc and Takeda Pharmaceutical Co Ltd, was terminated on Tuesday due to unauthorized release of study data. A statement from Cleveland Clinic, which was conducting the trial, said the study was being halted as unauthorized release of trial data by...

  • *Tie-up with Montreal scientists on heart disease genes. LONDON, May 13- AstraZeneca is diving deeper into personalised healthcare with two projects that move the concept beyond cancer into respiratory disorders and heart disease. To redress the balance, AstraZeneca said on Wednesday it had signed two deals, one with Abbott Laboratories for a diagnostic test...

  • *Nebraska becomes 16th U.S. state affected by avian flu. May 12- The fast-spreading avian flu virus was confirmed for the first time in Nebraska, at a commercial egg-laying farm that housed a flock of 1.7 million chickens, the U.S. Department of Agriculture said on Tuesday. "Unfortunately, Nebraska has joined a long list of states currently dealing with highly...

  • Orexigen says obesity drug safety trial terminated Tuesday, 12 May 2015 | 5:48 PM ET

    May 12- Orexigen Therapeutics Inc and its partner Takeda Pharmaceutical Co said they were terminating a trial assessing the cardiovascular safety of obesity drug, Contrave. Orexigen Therapeutics shares were down 12.5 percent in after market trading after falling 13.6 percent in regular trading on the Nasdaq on Tuesday. A statement from Cleveland Clinic,...

  • CHICAGO, May 12- The fast-spreading avian flu virus was confirmed for the first time in Nebraska, at a commercial egg-laying farm that housed a flock of 1.7 million chickens, the U.S. Department of Agriculture said Tuesday.

  • SAO PAULO, May 12- An epidemic of dengue fever is fanning public anger over what Brazilians say is President Dilma Rousseff's biggest challenge- the sad state of the national healthcare system. Health Minister Arthur Chioro has blamed the outbreak in part on a severe drought in Brazil's southeast, an area including Sao Paulo where dengue has been most prevalent.

  • 'Disruptor' Moderna: Human drug trials coming soon Tuesday, 12 May 2015 | 2:27 PM ET
    An image of Stéphane Bancel of Moderna Therapeutics from a company video.

    If successful, Moderna Therapeutics' cutting-edge drug method could be used to fight cancer and some infectious diseases.

  • Disruptor 50: No. 29 Intarcia Therapeutics Tuesday, 12 May 2015 | 7:00 AM ET
    Kurt Graves, CEO of Intarcia Therapeutics

    Investors believe Intarcia's drug-delivery system could very well upend the $55 billion worldwide market for treating Type-2 diabetes.

  • May 11- A strain of avian flu that until now had been found only in the Western United States has cropped up in Indiana, bringing the total number of states affected by the virulent outbreak to 15, the U.S. Department of Agriculture said on Monday. The H5N8 strain found in a backyard poultry flock in Indiana is concerning to them also. It was also found in captive...

  • UPDATE 1-USDA finds H5N8 bird flu strain in Indiana Monday, 11 May 2015 | 1:59 PM ET

    May 11- A strain of highly pathogenic H5 avian flu that had recently been found only in the Western United States has been confirmed in a backyard poultry flock in Indiana, the U.S. Department of Agriculture said on Monday. The H5N8 strain in Indiana is the same one that had been previously confirmed in the Pacific flyway, specifically in commercial chicken and...

  • GSK, US experts team up to find cure for AIDS Monday, 11 May 2015 | 9:22 AM ET
    AIDS, HIV, Africa

    Britain's GlaxoSmithKline is to collaborate with U.S. scientists in developing a cure for AIDS.

  • LONDON, May 11- Britain's GlaxoSmithKline, which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS. GSK is tapping into the latest expertise by creating an HIV Cure centre with the University of North Carolina at Chapel Hill and establishing a new jointly owned company.

  • Liberia declared Ebola-free after virus rampage Saturday, 9 May 2015 | 12:09 PM ET
    A nurse administers an injection on the first day of the Ebola vaccine study being conducted at Redemption Hospital, formerly an Ebola holding center, Feb. 2, 2015, in Monrovia, Liberia.

    The WHO declared Liberia free of Ebola, making it the first of 3 hardest-hit West African countries to bring an end to the epidemic.

  • Ebola survivor's eye still teeming with virus Friday, 8 May 2015 | 3:55 PM ET
    Dr. Steven Yeh, an ophthalmologist, examined Dr. Ian Crozier in March, five months after Dr. Crozier's initial recovery from Ebola.

    Ian Crozier, who survived Ebola, calls himself a poster child for 'post-Ebola syndrome,' which is also being reported in W. Africa, NYT reports.

  • 'Pollen tsunami' causes misery in the Northeast Thursday, 7 May 2015 | 3:21 PM ET
    Cloud of tree pollen

    A ferocious winter, delayed spring and climate change have created a "pollen tsunami" in the Northeast, NBC News reports.

  • J&J to evaluate 'compassionate use'   Thursday, 7 May 2015 | 2:36 PM ET
    J&J to evaluate 'compassionate use'

    Discussing the laws and ethics around compassionate use drugs, with Art Caplan, NYU School of Medicine; Dr. Amrit Ray, Janssen Pharmaceutical chief medical officer; and CNBC's Meg Tirrell.

  • NEW YORK, May 6- Drugmakers are building safety "switches" that can be used to turn off powerful cancer therapies known as CAR T cells when they cause life-threatening inflammation or attack healthy tissue. *Bellicum Pharmaceuticals Inc has developed a "switch" by genetically programming a CAR T cell to kill itself when exposed to a drug called rimiducid,...

  • NEW YORK, May 7- New therapies that clinical data show can eliminate blood cancers such as leukemia and lymphoma in 40 percent to 90 percent of patients may have to be genetically modified to include a switch that shields healthy cells from attack. The therapies could generate tens of billions of dollars in annual sales for drugmakers including Kite Pharma and...